Is Selective Use of Palivizumab Appropriate in Premature Infants?
More like this
- A Health Care Management Company's Experience with Palivizumab
- A Health Care Management Company's Experience With Palivizumab – 1 Year Later
- RSV Risk: Understanding RSV-Related Hospitalization of High-Risk Infants
- RSV Virology: Understanding RSV Seasonality and the Importance of Local Data
- Respiratory Synctial Virus (RSV): Prevention Strategies and the Appropriate Identification of Vulnerable Populations